Skip to content
AGENCY: Healthcare Demand Generation
Apply free

New Market Entry

New market entry, built from first principles for the market you're entering.

You've proven the product. Now you need to prove the market - in a country with a different buying culture, regulatory environment, and competitive landscape, where you have zero awareness, zero reference sites, and zero advocates. New market entry in healthcare isn't a repeat of your launch playbook. It's a rebuild from first principles, in a market that doesn't yet know why it should care.

Apply for a free 60 minutes with usRead the Positioning Guide
Portrait of a cross-cultural healthcare leader, representing new market entry and international expansion

Does this sound familiar?

The Empty Pipeline

You've hired a country manager or distributor. They have territory but no traction. Three months in, the pipeline is a list of people who took a business card at a conference and haven't returned a call.

The Translation Problem

You're using the same pitch that worked in your home market. It's not landing. The value proposition that resonated with UK surgeons doesn't resonate with German procurement committees or US hospital systems. Same product, different buying language.

The Credibility Gap

No local reference sites. No local advocates. No local case studies. Every conversation starts from zero because nobody in this market has seen your product work in their context. You're asking clinicians to be the first, and nobody wants to be first.

The Regulatory Maze

Different compliance frameworks. Different claims requirements. Different approval pathways. Your home market materials can't be used. Everything needs rebuilding for local regulatory reality.

Market entry isn't a product launch repeated. It's a credibility build from scratch.

Most companies treat new market entry as a distribution problem: find the right partner, give them materials, wait for orders. But distribution without demand generation is just having your product available in a market where nobody's looking for it.

The real challenge isn't logistics. It's building credibility, relevance, and awareness in a market where you have none. That requires local messaging, local proof, local advocates, and a go-to-market strategy designed for the market you're entering, not adapted from the market you're leaving.

Five continents taught us this: what works in one market almost never translates directly to another. But the methodology for figuring out what works, that translates everywhere.

You can't export a playbook. You have to build one for each market.

Diagnose. Build positioning. Create credibility. Execute.

Four phases. Each adapts to the local market; the methodology repeats. What we learn in month one shapes everything after.

01

Market diagnostic

Before anything else, we assess the market: competitive landscape, buying dynamics, regulatory environment, access pathways, and the specific barriers to adoption in this geography. Not assumptions from your home market. Primary research in the market you're entering.

02

Local messaging architecture

The 30-second pitch, the 2-minute story, the leave-behinds, all rebuilt for the local buying culture. The clinical value might be universal. The commercial language isn't. We build messaging that resonates with how this market actually buys.

03

Credibility build

No reference sites means no credibility. We design the first adopter strategy: how to identify, approach, and support your first local champions. KOL engagement. Early case study development. Advocacy programme design. The systematic approach to building the proof points this market needs to see.

What you walk away with.

Market Diagnostic Report

Competitive landscape, buying dynamics, regulatory requirements, access pathways, barriers to adoption. The document that tells you what you're walking into.

Local Messaging Architecture

Your product story, rebuilt for the local buying culture. 30-second, 2-minute, and 5-minute versions. Objection handling for local objections.

First Adopter Strategy

How to find, approach, and support your first local champions. KOL engagement plan. Reference site development roadmap. The credibility build, systematised.

Local Sales Playbook

What your local team says, how they say it, what they leave behind. Built for how this market buys. Not a translation of your home market playbook. A new build.

Digital Market Entry Plan

Website localisation, SEO for local search terms, content strategy for the new market, social presence. Being findable in the market you're entering.

Regulatory Claims Framework

Claims matrix built for local regulatory requirements. What you can say, what you can't, with evidence links. The foundation that lets your local team sell compliantly from day one.

Real markets. Real entry.

International · Enterprise

Contura · Arthrosamid international patient acquisition

Problem

A novel non-surgical knee treatment with low patient awareness in three target markets: UK, Germany, and Sweden. Each market had different patient profiles, regulatory standards, and private-pay dynamics. The clinical case was strong. The international acquisition system did not yet exist.

What we did

Patient persona development per market. Compliant messaging in each market with regulatory claims framework per country. Three persona-matched patient films. Meta paid social at scale. Per-market performance tracking. The system was designed to scale to new markets on the same infrastructure.

Result

285 patient enquiries in one month across three markets simultaneously, each a completed form routed to a clinic. One system, localised per market, with country-level dashboards and monthly reporting to the commercial team.

Read the full case study →

Growing Companies

Healthcare Data Platform, UK Market Entry

Problem

Complex product entering UK market. No local presence. No reference sites. Needed partnerships with major NHS trusts to establish credibility.

What we did

Market positioning. Messaging architecture for UK buyers. Sales enablement for local team. Stakeholder mapping across NHS trusts.

Result

Partnerships with King's College, St. George's, Nottingham, and Plymouth NHS Trusts. Local credibility established within 6 months.

Enterprise

Medical Device Company, European Expansion

Problem

Successful UK product. Entering Germany, France, and Benelux. Different buying cultures, different regulatory environments, different competitive landscapes. Same product, entirely different go-to-market requirements.

What we did

Market diagnostic per country. Local messaging architecture. Distributor enablement packs. Claims frameworks for each regulatory environment.

Result

First customers in all three markets within 9 months. Distributor enablement reduced onboarding from 6 months to 8 weeks.

* Arthrosamid is publicly named with the client's consent and has a full case study page. The other two are sector-disclosed under MNDA at client request; named references contactable on the triage call.

A country manager without a market entry strategy is a salary without a return.

A fully loaded UK field sales hire costs £80,000 to £165,000 a year. A distributor appointment takes 3-6 months to formalise. If they're selling without local messaging, local credibility, and a structured go-to-market plan, you're funding activity that looks productive but isn't converting.

Most failed market entries don't fail because the product doesn't work. They fail because the company exported a playbook that was designed for a different buying culture. By the time they realise, 12 months and £200K+ have been spent on a pipeline that doesn't exist.

The market entry framework costs less than one quarter of your country manager's salary. It's the difference between 12 months of activity and 12 months of traction.

Which situation are you in?

First international market

You've proven the model at home.

The product works. The model works. Now you need a go-to-market approach built for a new healthcare system with different procurement rules, different access dynamics, different stakeholders.

Underperforming expansion

You're in the market. It's not working.

Revenue exists but the curve isn't bending. Something structural is wrong. Usually the approach was translated rather than rebuilt. We diagnose and fix it.

Multi-market scaling

Repeating the first market, faster.

You've proven the international model. Now you need to replicate it efficiently across new geographies without rebuilding from scratch each time.

By stage

What this looks like for your business.

Growing Companies

First international market. Typically UK company entering Europe, or European company entering UK. Limited local resource. Need a complete go-to-market framework a small team can execute. Scope: market diagnostic, local messaging, first adopter strategy, sales playbook, digital market entry plan, event strategy. £15K-£40K / 3-6 months.

Enterprise

Multi-market expansion. Entering 2-5 markets simultaneously. Need consistent methodology with local adaptation. Distributor enablement across territories. Scope: multi-market diagnostic, global messaging framework with local adaptation, distributor enablement programme, claims frameworks per market, event portfolio strategy, attribution across markets. £40K-£100K+ / 6-12 months.

Questions we hear in every triage call.

Can't we just translate our existing materials?

Translation isn't localisation. The words might translate, but the buying dynamics don't. A UK pitch that leads with clinical evidence might need to lead with health economics in Germany. We rebuild, not translate.

We already have a distributor in that market.

Good. That's distribution, not demand generation. Your distributor can place the product. They typically can't build the awareness, credibility, and demand that creates the orders. That's what we do.

How do you know our target market?

We've launched across 5 continents. We know the methodology for assessing any healthcare market, competitive landscape, buying dynamics, regulatory environment, access pathways. We learn your market fast because we know what questions to ask.

This feels like a big investment before we've proven the market.

It's a smaller investment than 12 months of a country manager with no pipeline. The market entry framework is designed to prove viability fast. First customers in 4-9 months, not 18.

We need someone on the ground in that market.

We can work alongside your local team or distributor. We don't replace boots on the ground. We give those boots a plan, the right messaging, and a credibility-building roadmap.

What if the market isn't viable?

The diagnostic tells you that in the first 4 weeks, before you've committed to the full programme. Better to know early than to discover at month 12 that the competitive landscape or regulatory environment makes entry uneconomic.

Who delivers

Strategic Lead

Michael Colling-Tuck

20 years in healthcare marketing across five continents. 47 product launches. Built market entry strategies for global pharma and growing companies entering new geographies. The cross-market experience that makes the diagnostic faster and the playbook more realistic.

Commercial Modelling

Jason Quelch

ACCA-qualified. Builds the financial models that justify market entry investment. Revenue projections, breakeven analysis, distributor economics. The numbers your board needs before approving the expansion.

You might also need

Ready to talk?

60-minute triage call. No fee. No pitch. Bring your situation and we’ll tell you honestly whether we can help.

Apply for a free 60 minutes with usRead the Book

See what good looks like

The two campaign-type guides most relevant to this service.

Each guide names a single buyer decision and gives an opinionated read on the right answer for healthcare. Read them before the triage call and the conversation goes faster.

Campaign-type guide

Positioning & message-market fit

Read the guide

Campaign-type guide

Clinical evidence & KOL choreography

Read the guide

Or browse all eight guides

Healthcare innovations deserve recognition. We help them get it.